`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE WESTERN DISTRICT OF TEXAS
`AUSTIN DIVISION
`
`RAVGEN, INC.,
`
`Plaintiff,
`
`Civil Action No. 1:20-cv-00692-ADA
`
`v.
`
`JURY TRIAL DEMANDED
`
`NATERA, INC. AND NSTX, INC.,
`
`Defendants.
`
`ORDER REGARDING THE PARTIES’ DISCOVERY DISPUTE REQUESTS
`
`Before the Court are two discovery disputes between Plaintiff Ravgen, Inc. (“Ravgen”)
`
`and Defendants Natera, Inc. and NSTX, Inc. (“Natera”) in the above-captioned action, which arose
`
`via the Court’s OGP discovery dispute process.
`
`First, Natera seeks an order compelling Ravgen to produce the deposition transcript and
`
`related exhibits from the deposition of Dr. Ravinder Dhallan, Ravgen’s CEO and named inventor
`
`on the patent-in-suit, from Ravgen’s suits pending in the District of Delaware to use “as
`
`impeachment as necessary.” E.g., Ravgen, Inc. v. Biora Therapeutics, Inc., C.A. No. 20-cv-1734-
`
`RGA-JLH (D. Del.). Natera argues that Dr. Dhallan’s Delaware deposition testimony is relevant,
`
`admissible, and should be produced in this case with the accompanying exhibits “primarily simply
`
`for impeachment purposes.” Ravgen responds that Dr. Dhallan’s Delaware testimony is
`
`duplicative and cumulative of testimony from Dr. Dhallan already provided to Natera, and that its
`
`production is unfairly prejudicial to Ravgen.
`
`Second, Ravgen seeks an order compelling Natera to produce certain communications
`
`between Natera and/or its outside law firm and third-party Streck, Inc. (“Streck”) and/or its counsel
`
`
`
`Case 1:20-cv-00692-ADA Document 331 Filed 10/18/23 Page 2 of 2
`
`related to Ravgen, the Asserted Patents, and related IPRs/EPRs. Ravgen avers that the requested
`
`communications are not privileged, are relevant to (1) whether Natera is estopped under § 315(e)
`
`regarding Streck’s concluded IPR; and (2) the credibility of Streck’s trial witnesses, and should be
`
`produced. Natera responds that Ravgen’s request seeks materials that are privileged and/or work
`
`product and protected by the common interest doctrine.
`
`After consideration, including hearing oral argument on Natera’s Motion and Ravgen’s
`
`Motion on October 5, 2023, the Court finds that Natera’s Motion is GRANTED. Accordingly,
`
`Ravgen shall produce the transcript of Dr. Dhallan’s deposition from Ravgen’s suits pending in
`
`the District of Delaware and any exhibits thereto that are overlapping with this case. The Court
`
`further finds that Ravgen’s Motion is DENIED.
`
`SO ORDERED, this 18th day of October, 2023.
`
`ALAN D ALBRIGHT
`UNITED STATES DISTRICT JUDGE
`
`2
`
`